FDA announced today that the CDC PCR test for COVID-19 has failed its full review. Prefers laboratories to use a method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
On May 10, 2021 we reported that Sweden Stops using PCR Tests - RNA from Viruses can be Detected for Months After Infection now the CDC joins in confirming that PCR tests are inaccurate.
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
In other words the PCR test does not differentiate between influenza and COVID. 😲